20 results
Summary table of mechanism of action, side effect and contraindications of commonly used diabetic drugs. 

#pharmacology
Summary table of ... commonly used diabetic ... drugs. ... #pharmacology #dm2 ... #diabetes #medications
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
and sodium • Dosing ... binds magnesium • Dosing ... and calcium • Dosing ... #medications #pharmacology ... #table #comparison
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... medications, with ... kidney), which causes ... SGLT2 #Inhibitors #Pharmacology ... #Medications #DM2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... #Mellitus #DM2 ... #pharmacology # ... comparison #table
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors - Normal ... and Renal Dosing ... #Pharmacology # ... Management #Diabetes ... #DM2 #Endocrinology
Hyperkalemia - Differential Diagnosis Framework

PseudoHyperkalemia:
 • Lab error
 • Traumatic venipuncture
 • Hemolysis, thrombocytosis, leukocytosis
 •
Poorly controlled DM ... reactions Common Drugs ... (Uncontrolled diabetes ... Medications 2. ... differential #diagnosis #causes
Veltassa (Patiromer) 
MECHANISM: Potassium Binder 
INDICATION: Treatment of Hyperkalemia 
FORMULATION: Powder for oral suspension 
DOSING: 8.4
suspension DOSING ... drugs by at least ... with CKD, HF, or diabetes ... this from other drugs ... #Pharmacology
Hyperkalemia - Differential Diagnosis Framework

PseudoHyperkalemia:
 • Lab error
 • Traumatic venipuncture
 • Hemolysis, thrombocytosis, leukocytosis
 •
Poorly controlled DM ... reactions Common Drugs ... (Uncontrolled diabetes ... Medications 2. ... differential #diagnosis #causes
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Build a regimen using ... , the source case ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... peptidase 4), which normally ... not definitively cause ... #Summary #DM2 # ... diabetes #endocrinology